Given the substantial differences in fat mass among individuals with class II/III obesity, healthy controls, and those who underwent LSG, alterations in the activities of steroidogenic enzymes in adipose tissue, such as aromatase, may have further contributed to the observed differences. Here, CYP19A1 is linked to obesity disorder.